NCT03089814

Brief Summary

Changes in tissue microcirculation during ischemic conditioning (4 cycles of 5-min ischemia and 5-min reperfusion) has not been well documented. In previous studies, there was difference in changes in microcirculation, such as recovery slope and occlusion slope, between healthy subjects and cardiac surgery patients. Moreover, the occlusion slope, which reflects local tissue oxygen consumption during ischemic period, is anticipated to decrease during repeated ischemia-reperfusion cycle by its protecting effect, however there has not been well-conducted study. The purpose of the study is to evaluate the changes in microcirculation measured by tissue oxygen saturation during ischemic conditioning between healthy volunteers and cardiac surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

March 23, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 24, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2017

Completed
Last Updated

February 28, 2018

Status Verified

February 1, 2018

Enrollment Period

4 months

First QC Date

March 14, 2017

Last Update Submit

February 26, 2018

Conditions

Keywords

tissue oxygen saturation, ischemic conditioning

Outcome Measures

Primary Outcomes (1)

  • Changes in microcirculation during ischemic conditioning

    Changes in occlusion slope during ischemia and recovery slope during reperfusion

    During 4-cycles of 5-min ischemia followed by 5-min reperfusion

Study Arms (2)

Healthy volunteers

ACTIVE COMPARATOR

Healthy male volunteers will receive ischemic conditioning (4 cycles of 5-min ischemia followed by 5-min reperfusion on upper extremity) while measuring changes in tissue microcirculation at the thenar muscle.

Procedure: ischemic conditioning

Cardiac surgery patients

ACTIVE COMPARATOR

Patients scheduled for cardiac surgery will receive ischemic conditioning (4 cycles of 5-min ischemia followed by 5-min reperfusion on upper extremity) while measuring changes in tissue microcirculation at the thenar muscle.

Procedure: ischemic conditioning

Interventions

Four cycles of 5-min inflation of pneumatic cuff on upper extremity up to 200 mmHg, followed by 5-min deflation with no pressure.

Cardiac surgery patientsHealthy volunteers

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20-45
  • No underlying chronic disease
  • Male volunteer

You may not qualify if:

  • Under taking prescription drugs
  • Taking herbal medicines within 2 weeks
  • Baseline systolic blood pressure \> 150 mmHg or diastolic pressure \> 100 mmHg
  • Body mass index \< 18 kg/m\^2 or \> 30 kg/m\^2
  • Vigorous exercise, excessive alcohol, smoking or caffeine within 24 hours
  • Any abnormalities on upper extremities
  • Do not consent to participate
  • \<Cardiac surgery patients\>
  • Age 20-80
  • Scheduled for cardiac surgery
  • Baseline systolic blood pressure \> 150 mmHg or diastolic pressure \> 100 mmHg
  • Body mass index \< 18 kg/m\^2 or \> 30 kg/m\^2
  • Uncontrolled diabetes
  • Under taking beta-blockers
  • Severe renal dysfunction, chronic kidney disease, on hemodialysis
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

Study Officials

  • Yunseok Jeon, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 14, 2017

First Posted

March 24, 2017

Study Start

March 23, 2017

Primary Completion

July 10, 2017

Study Completion

July 10, 2017

Last Updated

February 28, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations